HIGHLIGHTS
- who: Kikuaki Yoshida and collaborators from the Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan have published the paper: Sudden Cardiac Death in a Patient with Thrombotic Thrombocytopenic Purpura: A Case Report, in the Journal: (JOURNAL)
- what: The authors report a case of refractory TTP involving sudden death due to inhibitor boosting.
SUMMARY
Thrombotic thrombocytopenic purpura (TTP) can cause life-threatening thrombotic microangiopathy by inducing severe deficiency in ADAMTS13 (a disintegrin-like and metalloproteinase with thrombospondin type 1 motifs 13) activity. Patients with acquired TTP are treated with plasma exchange . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.